|
340B Helps Low-Income Illinois Patients Get Needed Healthcare – Vote For HB 2371
Wednesday, Mar 4, 2026 - Posted by Advertising Department [The following is a paid advertisement.] Savings from the 340B program mean more comprehensive health services for the low-income and uninsured residents in your community. One in three Illinois households, about 1.5 million, lives on less than $50,000 per year. The calculus for drugmakers is exponentially larger. Pharmaceutical companies, many based overseas, are not invested in Illinois communities; they’re invested in their stock prices, profits and shareholder dividends.
• The United Kingdom’s AstraZeneca brought in nearly $59 billion in revenue last year, up 8% from 2024. It expects higher profits this year. • Switzerland’s Roche had over $70 billion in 2026 revenue and Denmark’s Novo Nordisk generated $46 billion. 340B is a small program with a big impact—small for drugmakers at just 3% of annual revenue, big for patients and the hospitals and Federally Qualified Health Centers (FQCHs) caring for them. With massive federal healthcare cuts looming—mostly impacting Medicaid patients—Illinois can’t afford to miss this opportunity to help patients struggling to make ends meet and providers facing closure or service line cuts ahead. Stand with patients, hospitals and FQHCs: Get House Bill 2371 across the finish line to restore the federal program in Illinois. Learn more.
|
